CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Israel

CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Israel



This, the industry analysis specialist, has released its latest report, CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Israel. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape in Israel. It identifies the key trends in the healthcare market and provides insights into the demographic, regulatory, reimbursement landscape and healthcare infrastructure of Israel.

Most importantly, the report provides valuable insights into the trends and segmentation of the pharmaceutical and medical device markets. It is built using data and information sourced from proprietary databases, secondary research, and in-house analysis by Thiss team of industry experts.
The Israeli pharmaceutical market was $1.85B in 2012.

This increased at a Compound Annual Growth Rate (CAGR) of 2.9% to $2.42B in 2018. The market is forecast to be $2.96B in 2025. The Israel medical device market was valued at $1.42B in 2015, which increased at a CAGR of 3.6% to reach $1.63B in 2019. The market is expected to grow at a CAGR of 4.5% from $1.7B in 2020 to $2.1B in 2025. The strong financial regulations and an export-driven, open-market economy have led Israel to economic growth, but strained political relationships with neighboring Arab countries and terrorism are pervasive threats.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in the Israel, and includes -
- An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
- Profiles and SWOT analyses of the major players in the pharmaceutical market (Sanofi, Pfizer, Novartis, GSK, and Teva Pharmaceuticals) and Profiles and SWOT analyses of the major players in the medical device market (Medtronic, Roche Diagnostics, Zimmer Biomet and Essilor)
- Detailed analysis about recent completed deals in the pharmaceutical and medical device market of Israel
- An insightful review of the reimbursement and regulatory landscape, of which analysis include details of the healthcare reimbursement process, the regulatory agencies and the approval processes for new drugs and medical devices
- Information regarding the health-tech landscape of the country along with the major health-tech deals
- Information regarding recent healthcare policies along with healthcare infrastructure and healthcare expenditure
- An overview of the opportunities and challenges to growth in the Israeli healthcare market

Reasons to buy

This report will enhance your decision-making capability by allowing you to -
- Develop business strategies by understanding the trends shaping and driving the Israeli healthcare market
- Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments, and companies likely to impact the healthcare market in the future
- Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing the performance of various competitors
- Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership
- Identify, understand, and capitalize on the opportunities and challenges in the Israeli healthcare market

1

1.2 List of Tables
2 Executive Summary
2.1 Executive Summary - Overview
2.2 Key Highlights
2.3 Key Highlights: Healthcare Start-Ups in Israel
2.4 Key Events: Israeli Pharmaceutical Timeline, 2014-2020
2.5 Key Events: Israeli Pharmaceutical Market
2.6 Key Events: M&A, VC & PE Deals, Global Pharmaceutical Market, 2019-2020
2.7 Key Events: Mergers and Acquisitions
2.8 Country Profile, Israel, 2019
3 Overview of Pharmaceutical Market
3.1 Pharmaceutical Market - Overview
3.2 Pharmaceutical Market - Government Initiatives
3.3 Pharmaceutical Market - Exports
3.4 Pharmaceutical Market - Imports
3.5 Pharmaceutical Market - Market Segments
3.6 Pharmaceutical Market - Major Players
4 Overview of Medical Devices Market
4.1 Medical Device Market - Overview
4.2 Medical Device Market - Major Segments
4.3 Medical Device Market - Major Players
5 Pharmaceutical and Medical Device Market - Drivers and Barriers
5.1 Drivers
5.2 Barriers
6 Deal analysis
6.1 Deal Analysis: M&A, VC, and PE Deals, Pharma Market, Israel 2019-2020
6.2 Deal Analysis: M&A, VC, and PE Deals, Pharmaceutical Market, Israel, 2019-2020
7 HealthTech Landscape
7.1 HealthTech Landscape, Israel
7.1.1 HealthTech Deals Landscape, Israel
7.2 Key HealthTech Deals, Israel
7.3 Digital Health Companies, Israel
7.4 Adoption of Technology in Healthcare, Israel
7.5 Effect of GDPR in Israel
7.6 HealthTech Landscape- Israel- Benefits and Risks
8 Market Access
8.1 Overview of Healthcare System, Israel
8.2 Overview of Health Insurance, Israel
8.3 Reimbursement Process, Israel
8.4 Healthcare Spending and Health Price Index, Israel
8.5 Pricing Policies, Israel
8.3 Regulatory Landscape, Israel
8.3.1 Market Authorization for Pharmaceutical Drugs, Israel
8.3.2 Market Authorization for Medical Devices, Israel
8.3.3 Licensing Process for Pharmaceutical and Medical Device Manufacturing
8.3.4 Licensing Process for Pharmaceutical Exports and Imports
8.3.5 Intellectual Property Rights, Patent, Israel
8.3.6 Intellectual Property Rights, Patent Prosecution Highway, Israel
8.3.7 Intellectual Property Rights, Trademark, Israel
8.3.8 Clinical Trial Regulations, Israel
8.3.9 Pharmaceutical Clinical Trials Landscape, Israel
8.3.10 Medical Devices Clinical Trials Landscape, Israel
8.3.11 Pharmaceutical Advertising Regulations, Israel
9.3.12 Labeling and Packaging Regulations, Israel
9 Country Healthcare Landscape
9.1 Healthcare Initiatives, Israel
9.2 Healthcare Facilities, Israel
9.3 Healthcare Parameters, Israel
9.4 Life Expectancy and Immunization Rate, Israel
9.5 Environmental Health, Israel
9.6 Healthcare Personnel, Israel
9.7 Disease Burden, Israel
9.8 Healthcare Expenditure
10 Trade Associations, Israel
11 Trade Fairs, Israel
12 Opportunities and Challenges
13 Appendix
13.1 Research Methodology
13.1.1 Coverage
13.1.2 Secondary Research
13.1.3 Forecasts
13.1.4 Expert Panel
13.2 Bibliography
13.3 Contact Us
13.4 Disclaimer

List Of Tables

Table 1: Dental Devices Market, Israel, Revenue ($M) and Market Share (%) of Major Companies, 2018
Table 2: In Vitro Diagnostic Devices Market, Israel, Revenue ($M) and Market Share (%) of Major Companies, 2018
Table 3: Ophthalmic Devices Market, Israel, Revenue ($M) and Market Share (%) of Major Companies, 2015
Table 4: Cardiovascular Devices Market, Israel, Revenue ($M) and Market Share (%) of Major Companies, 2018
Table 5: Diagnostic Imaging Market, Israel, Revenue ($M) and Market Share (%) of Major Companies, 2015
Table 6: Copayment Caps for Chronically Ill Patients, Israel, 2019
Table 7: Patent Fees, Israel, 2019
Table 8: Trademark Fees, Israel, 2019
Table 9: Trade Fairs, Israel

List Of Figures

Figure 1: Pharmaceutical Market, Israel, Revenue ($B), 2012-2019
Figure 2: Medical Device Market, Israel, Revenue ($B), 2015-2020
Figure 3: Healthcare Startups in Israel, Israel, 2019
Figure 4: Country Profile, Israel, 2019
Figure 5: Pharmaceutical Market, Israel, Revenue ($B), 2011-2018
Figure 6: Pharmaceutical Market, Israel, Revenue Forecast ($B), 2019-2025
Figure 7: Pharmaceutical Exports ($B), Israel, 2010-2018
Figure 8: Top Export Partners, Israel, 2018
Figure 9: Pharmaceutical Imports ($B), Israel, 2010-2018
Figure 10: Top Import Partners, Israel, 2018
Figure 11: Major Generic Drug Companies, Israel, 2019
Figure 12: OTC Market, Israel, Major Category (%), 2019
Figure 13: OTC Market, Israel, Revenue ($M), 2013-2020
Figure 14: Pharmaceutical Market, Major Players, 2018
Figure 15: Medical Device Market, Israel, Revenue ($B), 2015-2020
Figure 16: Medical Device Market, Israel, Revenue Forecast ($B), 2021-2025
Figure 17: Medical Devices Market, Major Segments (%), Israel, 2019
Figure 18: Dental Devices Market, Israel, Revenue ($M), 2015-2022
Figure 19: Dental Devices Market, Israel, Market Share of Major Players (%), 2018
Figure 20: In Vitro Diagnostic Devices Market, Israel, Revenue ($M), 2015-2022
Figure 21: In Vitro Diagnostic Devices Market, Israel, Market Share of Major Players (%), 2018
Figure 22: Ophthalmic Devices Market, Israel, Revenue ($M), 2015-2022
Figure 23: Ophthalmic Devices Market, Israel, Market Share of Major Players (%), 2015
Figure 24: Cardiovascular Devices Market, Israel, Revenue ($M), 2015-2022
Figure 25: Cardiovascular Devices Market, Israel, Market Share of Major Players (%), 2018
Figure 26: Diagnostic Imaging Market, Israel, Revenue ($M), 2015-2022
Figure 27: Diagnostic Imaging Market, Israel, Market Share of Major Players (%), 2015
Figure 28: Diagnostic Market, Israel, Revenue ($M), 2015-2020
Figure 29: Diagnostic Market, Israel, Revenue ($M), 2021-2025
Figure 30: Medical Device Market, Israel, Revenue ($B) of Major Companies, 2017
Figure 31: Deal Value and Deal Count, Pharmaceutical Market, Israel, 2019-2020
Figure 32: Deal Value and Deal Count Quarterly, Pharmaceutical Market, Israel, 2019-2020
Figure 33: Deal Value and Deal Count Sub-Types, Pharmaceutical Market, Israel, 2019-2020
Figure 34: Top Five Therapy Areas by Deal Value, Pharmaceutical Market, Israel, 2019-2020
Figure 35: Top Five Therapy Areas by Deal Number, Pharmaceutical Market, Israel, 2019-2020
Figure 36: M&A Deals by Therapy Area, Pharmaceutical Market, Israel, 2019-2020 (by value and by number)
Figure 37: Venture Financing Deals by Therapy Area, Pharmaceutical Market, Israel, 2019-2020 (by value and by number)
Figure 38: Private Equity Deals by Therapy Area, Pharmaceutical Market Israel, 2019-2020 (by value and by number)
Figure 39: Digital Health Subsectors (by Number of Companies), Israel, 2019
Figure 40: Investment and Funding Rounds, Israel, 2019
Figure 41: Major Startups Funding, Israel, 2019
Figure 42: Deal Value ($M), HealthTech, Israel, 2019
Figure 43: Deal Count (Number of Deals), HealthTech, Israel, 2019
Figure 44: Deal Value by Technology Theme ($M), HealthTech , Israel, 2019
Figure 45: Deal Count by Technology Theme (Number of Deals), HealthTech , Israel, 2019
Figure 46: Effect of GDPR on Israel, Israel, 2019
Figure 47: GDPR Guidelines, Israel, 2019
Figure 48: Overview of Healthcare System, Israel, 2019
Figure 49: Kupot Cholim (HMO), Israel, 2019
Figure 50: Private Health Insurance (% of population), Israel, 2010-2017
Figure 51: Israel Reimbursement Approval Process, Israel, 2019
Figure 52: Out-of-Pocket Expenditure ($ per capita), Israel, 2010-2017
Figure 53: Health Price Index, Israel, 2014-2018
Figure 54: New Drug Pricing Decree, Israel, 2018
Figure 55: Ministry of Health, Organization Chart, 2019
Figure 56: Drug Approval Process, Israel, 2018
Figure 57: Patent Application Process, Israel, 2019
Figure 58: Pharmaceutical Clinical Trials Count By Trial Status, Israel, 2018-2019
Figure 59: Pharmaceutical Clinical Trials Count By Phase, Israel, 2018-2019
Figure 60: Pharmaceutical Clinical Trials Count By Therapy Area, Israel, 2018-2019

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available